Core Team

Robert Chu
Recognizing the considerable potential of cloud and blockchain technologies in the healthcare industry and the need for better solves for care continuum and pervasive cyber-security issues, Robert founded Embleema in 2017 after a distinguished career at IBM and QuintilesIMS. Robert[...]
Read the bio
Nicolas Schmidt
Chief Product Officer
Nicolas is Chief Product Officer at Embleema. He focuses on building innovations that help patients regain control of their health data and share them transparently with research organizations. He is also co-chair of the Mobile Health Applications Working Group at[...]
Read the bio
Vahan Simonyan, PhD
Chief Scientist - WHISE-Embleema Health Blockchain Consortium
Dr. Vahan Simonyan has a solid scientific background in varied academic disciplines: MS in Physical Organic Chemistry, Ph.D. in Quantum Physics and Mathematics, post-doctoral training in Nanotechnology and Quantum Statistical Thermodynamics. After 2001, he switched his expertise to biotechnology and[...]
Read the bio
Alexis Normand
Head of Blockchain Consortium
A graduate of HEC (Msc.), Sciences-Po (MPA) and La Sorbonne in philosophy (Ba), Alexis has a background in public policy, healthcare reform and strategic consulting. In 2013, he created the B2B department of French start-up Withings, acquired by Nokia in[...]
Read the bio
Nathalie Lambert
Data Privacy Officer & Head of Partnerships
Read the bio
Sophie Martineau
VP of Sales
Read the bio
Matthieu Vegreville
Data Scientist
Read the bio
Brittany Sorice
UI/UX Lead
Read the bio
Benjamin Zirah
Business Development
Read the bio
Benjamin Apra
Bioinformatics Engineer
Read the bio
Yves Ordonneau
Technical Implementation and Operations Director
Read the bio

Advisory Board

Pr. John Halamka, MD
Professor of Innovation at Harvard Medical School
John D. Halamka, MD, MS, is a Professor of Medicine at Harvard Medical School, Chief Information Officer of Beth Israel Deaconess Medical Center, Chairman of the New England Healthcare Exchange Network (NEHEN), co-Chair of the national HIT Standards Committee, co-Chair[...]
Read the bio
Frederic Duchesne, Pharm.D.
CEO of Pierre Fabre Pharmaceuticals
Mr. Frederic Duchesne serves as the Chief Executive Officer of the Pharmaceuticals Division of Pierre Fabre, serving patients in more than 130 countries. He also serves as Managing Director Pharmaceutics of Pierre Fabre Investment Arm and is a Member of[...]
Read the bio
Adel Al-Saleh
CEO of T-Systems and Board Member of Deutsche Telekom
Before being appointed Member of the Board of Management of Deutsche Telekom AG and CEO of T-Systems effective January 1, 2018, Adel Al-Saleh was CEO of Northgate Information SolutionsGroup where he developed a turnaround strategy and drove a successful value[...]
Read the bio
Bernard Gilly, PhD
CEO at GenSight Biologics & Chairman at iBionext
Mr. Bernard Gilly, Ph.D. has over twenty years of experience in the financial and biotech sectors.He co-founded several disruptive technologies start-ups and is currently Chairman of Pixium Vision(2011), EyeTechCare (2012), Gecko Biomedical (2013) and Chronocam (2015). From 2005 to 2009,he[...]
Read the bio
Prashant Khambekar, PhD
Chief Blockchain Development Executive
Prashant has deep experience in Ethereum Blockchain development and oversees the development of the PatientTruth Proof-of-Concept. At Harbinger, his team has developed an Employee Verification system and a Vendor Payment system based on Ethereum. The systems are full-stack with Node.JS[...]
Read the bio


In 1951, Henrietta Lacks was admitted at John Hopkins hospital for cervical cancer. Her cells were extracted from her tumour and cultured. They became the HeLa immortal cell line, a source of invaluable medical data to present day, used to develop the first Polio Vaccine, cell cloning and to study HIV. Despite this outstanding contribution to research, Henrietta never gave her consent. She died in poverty with no compensation or acknowledgement until present day.

We believe we have the right as patients to choose how our data is used for the common good. As digital health becomes the norm, this means changing the very organization of the Internet to reclaim control.

Decentralization as Freedom

The promise of the Internet has been broken. Decentralization of information was meant to promote ​free speech, democratize ​knowledge, abolish censorship, expand services remotely… But the Internet is now centralized by a handful of platforms. They monetize our data as their own asset to make us better consumers, not more enlightened or healthier citizens at the expense of working and innovating for the common good. Our data is nothing less than our digital assets in the virtual world and the same way we own and are free to dispose of our assets in the real-world, we should own and dispose of our digital assets.

Our healthcare data is our most valuable digital asset: it can save our life in an emergency situation and provides critical decision-making information for the providers to offer us the best care. However, our records are held captive in protected silos for fear of being singled out, for fear of seeing our right to care violated. A wealth of digital data is lost to personalized medicine.

Power to the Patients

We want to become the steward of our health data, not having to rely on third parties to handle our most sensitive information. We have the right to break information silos, control where our data is stored, who has access to it, who we share it with. This power can dramatically affect how treatments are delivered, moving away from a top-down approach to an iterative process where we, patients, measure the effectiveness of more personalized treatments. This is a paradigm for medical research and change lives.

In nodes we trust

As third parties centralize our confidential data, unauthorized access becomes the norm. We, as patients, are kept out of the loop even in case of breaches. Decentralized ledgers let us enforce the security over our digital health assets, making tampering impossible, keeping track of violations in real-time, without no third party involved. Imagine we could still control our data even once it has been shared, removing access to enforce our privacy at any time.

We believe in reclaiming our data with decentralized networks, to put patients at the center of care.

Your Health Data, Your Property

Hospitals or pharmacies monetize our health data to pharmaceutical and insurance companies for marketing or pharmacovigilance studies. Even though there are strong benefits for using our data, we are not taking part in the sale of our own data. Blockchain will let us enforce our property. Smart contracts will let us set the terms by which others access our digital assets. Instead of being robbed of our data, we will willingly get involved and be compensated for our contribution to the development of innovative treatments.

Holding Blockchain to the Highest Standards

Blockchain as a trust-generating technology is game-changing, destined to become the standard in industries that need trustworthy information without rent-seeking third parties. But its potential is shrouded by a wave of crypto-speculation that make the most solid projects look suspicious. To restore trust and allow news rights to come of age, we deliver real products with clear benefits, demonstrate financial transparency, and share our expertise to the healthcare ecosystem. We are working with regulators, health authorities, pharmaceutical companies, patient advocacy groups, care networks and providers to ensure patients, caregivers and researchers can reliably endorse the next generation of healthcare data.

[contact-form-7 id="579" title="Investment Form"]

Embleema ICO Public Sale Coming Soon